MedTrace Logo

Perioperative Patient Skin Antiseptic Preparation Evaluation

NCT04756804 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2024-03-20

Study results available
· View outcomes & findings →

Summary

This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.

Conditions

  • Surgical Site Infection

Interventions

DRUG

70% v/v Isopropyl Alcohol Surgical Solution

Patient preoperative skin preparation

DRUG

2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol

Patient preoperative skin preparation

Sponsors & Collaborators

  • Zurex Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph P Hart, MD, FACS, DFSVS · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2022-09-29
Completion
2022-09-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756804 on ClinicalTrials.gov